Compare · PG vs WALD
PG vs WALD
Side-by-side comparison of Procter & Gamble Company (PG) and Waldencast plc (WALD): market cap, price performance, sector, and recent activity on the wire.
Summary
- Both PG and WALD operate in Package Goods/Cosmetics (Consumer Discretionary), so they compete in similar markets.
- PG is the larger of the two at $337.97B, about 1932.4x WALD ($174.9M).
- Over the past year, PG is down 6.8% and WALD is down 13.6% - PG leads by 6.8 points.
- PG has been more active in the news (44 items in the past 4 weeks vs 4 for WALD).
- PG has more recent analyst coverage (25 ratings vs 11 for WALD).
- Company
- Procter & Gamble Company
- Waldencast plc
- Price
- $145.40-0.83%
- $1.37+1.48%
- Market cap
- $337.97B
- $174.9M
- 1M return
- -2.18%
- -19.88%
- 1Y return
- -6.81%
- -13.56%
- Industry
- Package Goods/Cosmetics
- Package Goods/Cosmetics
- Exchange
- NYSE
- NASDAQ
- IPO
- 2021
- News (4w)
- 44
- 4
- Recent ratings
- 25
- 11
Procter & Gamble Company
The Procter & Gamble Company provides branded consumer packaged goods to consumers in North and Latin America, Europe, the Asia Pacific, Greater China, India, the Middle East, and Africa. It operates in five segments: Beauty; Grooming; Health Care; Fabric & Home Care; and Baby, Feminine & Family Care. The Beauty segment offers conditioners, shampoos, styling aids, and treatments; and antiperspirants and deodorants, personal cleansing, and skin care products under the Head & Shoulders, Herbal Essences, Pantene, Rejoice, Olay, Old Spice, Safeguard, Secret, and SK-II brands. The Procter & Gamble Company was founded in 1837 and is headquartered in Cincinnati, Ohio.
Waldencast plc
Waldencast Acquisition Corp. focuses on effecting a merger, share exchange, asset acquisition, share purchase, reorganization, or similar business combination with one or more businesses. It intends to identify businesses in the beauty, personal care, and wellness sectors. The company was incorporated in 2020 and is based in White Plains, New York.
Latest PG
- SVP - Chief Accounting Officer Janzaruk Matthew W. sold $52,141 worth of shares (359 units at $145.24), decreasing direct ownership by 22% to 1,271 units (SEC Form 4)
- Chf Rsch, Dev & Innov Officer Aguilar Moses Victor Javier sold $438,991 worth of shares (3,053 units at $143.79), decreasing direct ownership by 6% to 49,511 units (SEC Form 4)
- CEO-Baby and Feminine Care Abd El Hak Hesham sold $278,377 worth of shares (1,936 units at $143.79), decreasing direct ownership by 15% to 11,218 units (SEC Form 4)
- CEO-Fabric Home & Habitat Care Raman Sundar G. sold $491,274 worth of shares (3,435 units at $143.02), decreasing direct ownership by 7% to 47,745 units (SEC Form 4)
- CEO - Grooming Santos De Azevedo Juliana Monteiro sold $340,495 worth of shares (2,368 units at $143.79), decreasing direct ownership by 9% to 23,601 units (SEC Form 4)
- SVP - Chief Accounting Officer Janzaruk Matthew W. sold $22,431 worth of shares (156 units at $143.79), decreasing direct ownership by 9% to 1,630 units (SEC Form 4)
- Chief Financial Officer Schulten Andre sold $776,754 worth of shares (5,402 units at $143.79), decreasing direct ownership by 8% to 62,975 units (SEC Form 4)
- CEO - Beauty Bharucha Freddy P. sold $35,372 worth of shares (246 units at $143.79), decreasing direct ownership by 11% to 1,965 units (SEC Form 4)
- Chief Human Resources Officer Purushothaman Balaji sold $290,312 worth of shares (2,019 units at $143.79), decreasing direct ownership by 12% to 15,477 units (SEC Form 4)
- Chairman, President and CEO Jejurikar Shailesh sold $888,047 worth of shares (6,176 units at $143.79), decreasing direct ownership by 14% to 39,326 units (SEC Form 4)
Latest WALD
- SEC Form 4 filed by Chief Executive Officer Brousset Michel
- SEC Form 4 filed by Chief Growth Officer Sebti Hind
- Chief Financial Officer Manfredi Manuel converted options into 79,289 units of Class A Ordinary Shares, increasing direct ownership by 200% to 118,933 units (SEC Form 4)
- SEC Form 6-K filed by Waldencast plc
- SEC Form 6-K filed by Waldencast plc
- SEC Form 6-K filed by Waldencast plc
- Waldencast Announces Completion of the Sale of Obagi Medical to Bridgepoint
- SEC Form 6-K filed by Waldencast plc
- SEC Form 6-K filed by Waldencast plc
- Obagi Medical Announces FDA Approval of Obagi® saypha® ChIQ™ Injectable Hyaluronic Acid Gel